Presentation Operator Message
Operator (Operator)
Good day, and thank you for standing by. Welcome to the results of LEGEND Phase II combination trial with lanifibranor and Empagliflozin in patients
I
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 5,520 EUR | +7,18% |
|
+12,65% | +39,92% |
| 15/01 | Inventiva S.A. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 through Jan-16-2026 | |
| 07/01 | INVENTIVA S.A. : UBS stelt koopadvies voor | ZM |
Gepubliceerd op 19-03-2024 om 13:00
Presentation Operator Message
Operator (Operator)
Good day, and thank you for standing by. Welcome to the results of LEGEND Phase II combination trial with lanifibranor and Empagliflozin in patients
I
Kies jouw editie
Alle financiële informatie op nationaal niveau